biblio
“Cocrystallization of multi-kinase inhibitor pazopanib with fenamic acids: improving dissolution and inhibiting cell migration”, CrystEngComm, vol. 25, no. 39, pp. 5565-5574, 2023.
, “Dabrafenib-panobinostat salt: improving the dissolution rate and inhibition of BRAF melanoma cells”, ACS Omega, vol. 8, no. 20, pp. 18255-18265, 2023.
, “Inhibitory effect of curcumin-artemisinin co-amorphous on Tau aggregation and Tau phosphorylation”, Colloid and Surfaces B-Biointerfaces, vol. 221, 2023.
, “Polymorph II of hydroxyurea 150 years after its first synthesis”, Crystengcomm, vol. 25, no. 18, pp. 2712-2716, 2023.
, “The effects of cis and trans butenedioic acid on the physicochemical behavior of lumefantrine”, Crystengcomm, vol. 24, no. 1, pp. 156-168, 2022.
, “Fluorobenzoic acid coformers to improve the solubility and permeability of the BCS class IV drug naftopidil”, Chemical Communications, vol. 58, no. 37, pp. 5582-5585, 2022.
, “Novel crystal forms of Entresto: a supramolecular complex of trisodium sacubitril/valsartan hemi-pentahydrate”, Crystengcomm, vol. 24, no. 42, pp. 7387-7393, 2022.
, “Synthesis of ternary cocrystals, salts, and hydrates of acefylline with enhanced dissolution and high permeability”, Crystal Growth & Design, vol. 22, no. 7, pp. 4165–4181, 2022.
, “Can we identify the salt-cocrystal continuum state using XPS?”, Crystal Growth & Design, vol. 21, no. 2, pp. 735-747, 2021.
, “Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation”, Crystengcomm, vol. 23, no. 1, pp. 227-237, 2021.
, “Entacapone polymorphs: crystal structures, dissolution, permeability, and stability”, Crystal Growth & Design, vol. 21, no. 10, pp. 5573-5585, 2021.
, “Salts, solvates and hydrates of the multi-kinase inhibitor drug pazopanib with hydroxybenzoic acids”, Crystengcomm, vol. 23, no. 35, pp. 5994-6011, 2021.
, “Generation and evaluation of pharmacologically relevant drug-drug cocrystal for gout therapy”, Crystal Growth & Design, vol. 20, no. 6, pp. 3577-3583, 2020.
, “Improving the dissolution rate of the anticancer drug dabrafenib”, Crystal Growth & Design, vol. 20, no. 2, pp. 1035-1046, 2020.
, “Naftopidil molecular salts with improved dissolution and permeation”, Crystal Growth & Design, vol. 20, no. 5, pp. 3064-3076, 2020.
, “Novel pharmaceutical cocrystals and salts of bumetanide”, Crystal Growth & Design, vol. 20, no. 2, pp. 793-803, 2020.
, “Salts and cocrystal of etodolac: advantage of solubility, dissolution, and permeability”, Crystal Growth & Design, vol. 20, no. 7, pp. 4512-4522, 2020.
, “Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation”, European Journal of Pharmaceutical Sciences, vol. 139, 2019.
, “Crystal engineering: an outlook for the future”, Angewandte Chemie-International Edition, vol. 58, no. 13, pp. 4100-4107, 2019.
, “Hepatoprotective cocrystals of isoniazid: synthesis, solid state characterization, and hepatotoxicity studies”, Crystal Growth & Design, vol. 19, no. 09, pp. 5161-5172, 2019.
, “High-solubility salts of the multiple sclerosis drug teriflunomide”, Crystal Growth & Design, vol. 19, no. 09, pp. 5407-5417, 2019.
, “Education with a purpose”, Current Science, vol. 115, no. 1, pp. 20-21, 2018.
,